PP
CABA icon

PDT Partners’s Cabaletta Bio CABA Stock Holding History

PDT Partners’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,956
Closed -$133K – 878
2021
Q3 		$133K Sell
10,956
-3,444
-24% -$31.8K 0.01% 724
2021
Q2 		$124K Buy
+14,400
New +$141K 0.01% 750
2020
Q4 		– Sell
-14,183
Closed -$154K – 705
2020
Q3 		$154K Buy
14,183
+1,438
+11% +$16.5K 0.01% 654
2020
Q2 		$142K Buy
+12,745
New +$97.6K 0.01% 611

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PDT Partners's CABA Position: Q4 2021 in Review

PDT Partners sold out of Cabaletta Bio (CABA) in Q4 2021, closing a stake of 10,956 shares — an estimated $133K sold.

PDT Partners first reported a position in CABA in Q2 2020 and held it in 4 quarters. The position peaked at $154K in Q3 2020. 66 funds tracked by Wall St. Rank hold CABA as of Q4 2021.

  • PDT Partners reported no remaining Cabaletta Bio position as of Q4 2021 after selling out during the quarter.
  • PDT Partners sold 10,956 Cabaletta Bio shares in Q4 2021, an estimated $133K.
  • PDT Partners first reported a position in Cabaletta Bio in Q2 2020 and held it in 4 quarters.
  • PDT Partners's Cabaletta Bio position peaked at $154K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2021.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.